GW Pharmaceuticals SWOT Analysis
GW Pharmaceuticals is one of the leading brands in the pharma and healthcare sector. GW Pharmaceuticals SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of GW Pharmaceuticals:
Quick Glance:
GW Pharmaceuticals Strengths
- GW Pharmaceuticals has the only cultivation license in the United Kingdom from the Home Office and theMHRA, to cultivate cannabis from seeds and clones to conduct scientific research concerning the medicinal uses of the plant
- GW Pharmaceuticals concluded a partnership with Bayer for the distribution of Sativex in North America
- GW is researching a large number of cannabinoids, each of which has different effects and applications
- Collaboration with various educational institutes for R&D.
- Strong expertise in the industry
Above are the strengths in the SWOT Analysis of GW Pharmaceuticals. The strengths of GW Pharmaceuticals looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
GW Pharmaceuticals Weaknesses
- Health issues due to side effects of cannabis
- Human rights issues as cannabis is considered as a harmful drug
- Legal issues in cultivating medical cannabis
- Requires very high quality control in cultivating medical cannabis
These were the weaknesses in the GW Pharmaceuticals SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
GW Pharmaceuticals Opportunities
- Its cannabis-based product, Epidiolex, developed for experimental treatment of epilepsy, will undergo stage-two trials in the US in 2014
- Tie ups with large hospitals can be a huge opportunity
- Scope of entering into other segments of pharmaceuticals
Above we covered the opportunities in GW Pharmaceuticals SWOT Analysis. The opportunities for any brand can include prospects of future growth.
GW Pharmaceuticals Threats
- It has only one major drug Sativex, contribute maximum to the revenue
- Need for continuous innovation
- Stringent government rules and quality control measures
The threats in the SWOT Analysis of GW Pharmaceuticals are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the GW Pharmaceuticals SWOT analysis.
Continue reading more about the brand/company.
About GW Pharmaceuticals
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| GW Pharmaceuticals Overview | |
|---|---|
| Parent Company |
GW Pharmaceuticals |
| Category |
Biopharmaceutical |
| Sector | |
| Tagline/ Slogan |
- |
| USP |
Its MS treatment product |
| GW Pharmaceuticals STP | |
| Segmentation |
Healthcare |
| Target Market |
People suffering from multiple sclerosis, epilepsy and cancer |
| Positioning |
Focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform |
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Browse marketing analysis of more brands and companies similar to GW Pharmaceuticals. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
